Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants

NCT03085329 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT03085329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03085329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy of Seattle-PAP for the Respiratory Support of Premature Infants
Lead sponsor
Seattle Children's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
February 10, 2017
Completion date
February 9, 2019
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature birth